Evidence map›Paper›PMID 41102444›Full record

ArticleNature biotechnology2026

Accurate somatic small variant discovery for multiple sequencing technologies with DeepSomatic.

Jimin Park, Daniel E Cook, Pi-Chuan Chang, Alexey Kolesnikov, Lucas Brambrink, Juan Carlos Mier, Joshua Gardner, Brandy McNulty, Samuel Sacco, Ayse G Keskus and 26 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Clonal selection of somatic mutations shapes NK cell memory.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. A complete human pancreatic cancer genome.bioRxiv : the preprint server for biology · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

36 authors.

Jimin Park *UC Santa Cruz Genomics Institute, University of California, Santa Cruz, CA, USA.
Daniel E Cook *Google Inc., Mountain View, CA, USA.
Pi-Chuan ChangGoogle Inc., Mountain View, CA, USA.ORCID http://orcid.org/0000-0003-3021-6446
Alexey KolesnikovGoogle Inc., Mountain View, CA, USA.
Lucas BrambrinkGoogle Inc., Mountain View, CA, USA.
Juan Carlos MierGoogle Inc., Mountain View, CA, USA.
Joshua GardnerUC Santa Cruz Genomics Institute, University of California, Santa Cruz, CA, USA.
Brandy McNultyUC Santa Cruz Genomics Institute, University of California, Santa Cruz, CA, USA.
Samuel SaccoUC Santa Cruz Genomics Institute, University of California, Santa Cruz, CA, USA.
Ayse G KeskusCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-3934-8587
Asher BryantCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.ORCID http://orcid.org/0009-0005-9132-782X
Tanveer AhmadCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
Jyoti ShettySequencing Facility, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Yongmei ZhaoSequencing Facility Bioinformatics Group, Biomedical Informatics and Data Science Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.ORCID http://orcid.org/0000-0003-0800-4658
Bao TranSequencing Facility, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Giuseppe NarzisiNew York Genome Center, New York, NY, USA.ORCID http://orcid.org/0000-0003-1118-8849
Adrienne HellandNew York Genome Center, New York, NY, USA.
Byunggil YooChildren's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
Irina PushelChildren's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.ORCID http://orcid.org/0000-0002-0862-1923
Lisa A LansdonChildren's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.ORCID http://orcid.org/0000-0002-8214-6083
Chengpeng BiChildren's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
Adam WalterChildren's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
Margaret GibsonChildren's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
Tomi PastinenChildren's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.ORCID http://orcid.org/0000-0003-4016-5021
Rebecca ReimanTranslational Genomics Research Institute, Phoenix, AZ, USA.
Sharvari MankameTranslational Genomics Research Institute, Phoenix, AZ, USA.
T Rhyker Ranallo-BenavidezTranslational Genomics Research Institute, Phoenix, AZ, USA.ORCID http://orcid.org/0000-0003-3137-8439
Christine BrownCity of Hope Beckman Research Institute and Medical Center, Duarte, CA, USA.ORCID http://orcid.org/0000-0003-4915-8207
Nicolas RobineNew York Genome Center, New York, NY, USA.ORCID http://orcid.org/0000-0001-5698-8183
Floris P BarthelTranslational Genomics Research Institute, Phoenix, AZ, USA.ORCID http://orcid.org/0000-0002-7425-4180
Midhat S FarooqiChildren's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.ORCID http://orcid.org/0000-0002-5238-1349
Karen H MigaUC Santa Cruz Genomics Institute, University of California, Santa Cruz, CA, USA.ORCID http://orcid.org/0000-0002-3670-4507
Andrew CarrollGoogle Inc., Mountain View, CA, USA. awcarroll@google.com.ORCID http://orcid.org/0000-0002-4824-6689
Mikhail KolmogorovCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA. mikhail.kolmogorov@nih.gov.ORCID http://orcid.org/0000-0002-5489-9045
Benedict PatenUC Santa Cruz Genomics Institute, University of California, Santa Cruz, CA, USA. bpaten@ucsc.edu.ORCID http://orcid.org/0000-0001-8863-3539
Kishwar ShafinGoogle Inc., Mountain View, CA, USA. shafin@google.com.ORCID http://orcid.org/0000-0001-5252-3434

Funding

The WashU-UCSC-EBI Human Genome Reference Center."U41HG010972 · NHGRI · WASHINGTON UNIVERSITY · PI Ting Wang · 2019 to 2026
$24.9M
Dockstore: The Community Platform for Reproducible Biomedical Workflows and ApplicationsU24HG011853 · NHGRI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Jonathan Lawson, Benedict Paten · 2021 to 2026
$5.7M
Computational tools for uniform processing and integration of human reference atlas data [2 of 5]OT2OD033761 · OD · CARNEGIE-MELLON UNIVERSITY · PI PATEN, BENEDICT, RUFFALO, MATTHEW · 2022 to 2025
$4.2M
Enabling Comparative PangenomicsR01HG010485 · NHGRI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI HAUSSLER, DAVID H, MARTIN, FERGAL JAMES · 2020 to 2023
$2.6M
Advanced development of Lancet, an emerging tool for complex variant calling in cancer genomicsU01CA253405 · NCI · NEW YORK GENOME CENTER · PI NARZISI, GIUSEPPE · 2021 to 2023
$1.5M
U.S. Department of Health & Human Services | National Institutes of Health (NIH) OT2OD033761U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01HG010485U.S. Department of Health & Human Services | National Institutes of Health (NIH) U24HG011853U.S. Department of Health & Human Services | National Institutes of Health (NIH) U41HG010972U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) U01CA253405
6 · The paper itself

Abstract

Somatic variant detection is an integral part of cancer genomics analysis. While most methods have focused on short-read sequencing, long-read technologies offer potential advantages in repeat mapping and variant phasing. We present DeepSomatic, a deep-learning method for detecting somatic small nucleotide variations and insertions and deletions from both short-read and long-read data. The method has modes for whole-genome and whole-exome sequencing and can run on tumor-normal, tumor-only and formalin-fixed paraffin-embedded samples. To train DeepSomatic and help address the dearth of publicly available training and benchmarking data for somatic variant detection, we generated and make openly available the Cancer Standards Long-read Evaluation (CASTLE) dataset of six matched tumor-normal cell line pairs whole-genome sequenced with Illumina, PacBio HiFi and Oxford Nanopore Technologies, along with benchmark variant sets. Across samples, both cell line and patient-derived, and across short-read and long-read sequencing technologies, DeepSomatic consistently outperforms existing callers.

Indexed as

Deep LearningHigh-Throughput Nucleotide SequencingNeoplasmsSequence Analysis, DNACell Line, TumorExome SequencingGenetic VariationGenomicsHumansWhole Genome Sequencing

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.